Change in Director / Key Managerial Personnel

  • Nature of change: Appointment of Chief Financial Officer (CFO) and Key Managerial Personnel (KMP)
  • Name and DIN: Ms. Reenah Simon Joseph (DIN not disclosed in the filing)
  • Effective date: Appointment is effective from August 31, 2026
  • Tenure: Term of appointment is as per appointment letter (specific duration not disclosed)
  • Profile and qualifications: Ms. Reenah Simon Joseph is a finance and corporate strategy leader with approximately 19 years of experience. Her most recent role was as Deputy Group CFO and Head of Corporate Finance, M&A and Investor Relations at PDS Limited. Previously, she was associated with Future Group as Chief Corporate Finance & Investor Relations and with Credit Suisse Securities as Senior Analyst in the Investment Banking Division. Her experience spans capital markets, fundraising, M&A, investor relations, financial governance, FP&A, business transformation, strategic planning, performance management, and stakeholder management. She holds an MBA in Finance from ICFAI Business School, Pune.
  • Eligibility confirmation: The disclosure confirms the appointment is in pursuance to the provisions of the Companies Act, 2013, read with Rules thereunder and SEBI Listing Regulations, implying compliance with eligibility norms, though no specific declaration of non-disqualification is mentioned.
  • Relationship with other directors: Not Applicable (as per the disclosure)
  • Previous KMP: The filing does not disclose information about the previous CFO or the nature of their exit, nor does it indicate whether this succession was planned or interim.
  • Governance implications: As the appointment is for the CFO role, there are inherent financial oversight implications, though the disclosure does not elaborate on specific governance changes or implications.

Key Financial or Operational Approvals

  • No financial results, fundraising, acquisitions, capital infusion, business restructuring, or dividend declarations were mentioned in this disclosure.
  • The board meeting specifically addressed only the appointment of the CFO among its agenda items.

Strategic or Business Context

  • No business outlook, risk commentary, demand trends, regulatory developments, or macro/micro headwinds were discussed.
  • No segment-wise insights, restructuring actions, cost measures, expansion plans, or capex announcements were included.
  • No forward-looking actions or guidance were provided.
  • No references to liquidity position, leverage, working capital, or refinancing plans were made.

Any Other Material Information

  • Committee involvement: The appointment was based on recommendations from both the Nomination and Remuneration Committee and the Audit Committee.
  • Regulatory compliance: The disclosure is made under Regulation 30 of the SEBI Listing Regulations with reference to SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
  • Board meeting details: The meeting was held on August 29, 2026, commencing at 05:20 PM (IST) and concluding at 05:35 PM (IST).
  • Company information: Aequs Limited (formerly Aequs Private Limited), CIN: L80302KA2000PLC026760. Registered Office: Aequs Tower, No. 55, Whitefield Main Road, Mahadevapura Post, Bengaluru - 560048, Karnataka. Corporate Office: Aequs SEZ, No. 437/A, Hattargi Village, Hukkeri Taluk, Belagavi – 591243, Karnataka.
  • Contact: investor.relations@aequs.com
  • Scrip symbols: NSE: AEQUS, BSE: 544634